Seminars in Diagnostic Pathology
Volume 23, Issue 1 , Pages 20-24 , February 2006

Use of mesothelin as a marker for mesothelial cells in cytologic specimens

Presented in part at the Annual Meeting of the United States and Canadian Academy of Pathology, Vancouver, BC, Canada, March 2004.

References 

  1. Domagala W , Woyke S . Transmission and scanning electron microscopic studies of cells in effusions . Acta Cytol . 1975;19:214–224
  2. Bauer Z , Milic N , Handl S , et al.   The results of some cytochemical reactions in metastatic malignant tumor cells in pleural and peritoneal effusions . Acta Cytol . 1977;21:141–146
  3. Koss LG , Domagala W . Configuration of surfaces of human cancer cells in effusions (A review) . Scanning Electron Microscopy . 1980;3:89–100
  4. Unger KM , Raber M , Bedrossian CW , et al.   Analysis of pleural effusions using automated flow cytometry . Cancer . 1983;52:873–877
  5. Ghosh AK , Spriggs AI , Taylor-Papadimitriou J , et al.   Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies . J Clin Pathol . 1983;36:1154–1164
  6. Halter SA , Hunt LS , Roche B , et al.   Backscatter electron imaging of cells from effusions . Scanning Electron Microscopy . 1984;4:1883–1892
  7. Walts AE , Said JW , Shintaku IP , et al.   Keratins of different molecular weight in exfoliated mesothelial and adenocarcinoma cells: an aid to cell identification . Am J Clin Pathol . 1984;81:442–446
  8. Bousfield LR , Greenberg ML , Pacey F . Cytogenetic diagnosis of cancer from body fluids . Acta Cytol . 1985;29:768–774
  9. Mason MR , Bedrossian CW , Fahey CA . Value of immunocytochemistry in the study of malignant effusions . Diagn Cytopathol . 1987;3:215–221
  10. Cibas ES , Corson JM , Pinkus GS . The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen . Hum Pathol . 1987;18:67–74
  11. Silverman JF , Nance K , Phillips B , et al.   The use of immunoperoxidase panels for the cytologic diagnosis of malignancy in serous effusions . Diagn Cytopathol . 1987;3:134–140
  12. Esteban JM , Yokota S , Husain S , et al.   Immunocytochemical profile of benign and carcinomatous effusions (A practical approach to difficult diagnosis) . Am J Clin Pathol . 1990;94:698–705
  13. Delahaye M , Hoogsteden HC , Van der Kwast TH . Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma . J Pathol . 1991;165:137–143
  14. Nance KV , Silverman JF . Immunocytochemical panel for the identification of malignant cells in serous effusions . Am J Clin Pathol . 1991;95:867–874
  15. Chang K , Pai LH , Pass H , et al.   Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma . Am J Surg Pathol . 1992;16:259–268
  16. Donna A , Betta PG , Bellingeri D , et al.   Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibody . Diagn Cytopathol . 1992;8:361–365
  17. Clark SP , Chou ST , Martin TJ , et al.   Parathyroid hormone-related protein antigen localization distinguishes between mesothelioma and adenocarcinoma of the lung . J Pathol . 1995;176:161–165
  18. Fetsch PA , Abati A , Hijazi YM . Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology . Cancer . 1998;84:101–108
  19. Skov BG , Stahel RA , Hirsch F . ME1-antibody labelling of primary bronchogenic tumours and extrapulmonary malignancies . Lung Cancer . 1994;11:221–227
  20. Rogers JH . Calretinin: a gene for a novel calcium-binding protein expressed principally in neurons . J Cell Biol . 1987;105:1343–1353
  21. Doglioni C , Tos AP , Laurino L , et al.   Calretinin: a novel immunocytochemical marker for mesothelioma . Am J Surg Pathol . 1996;20:1037–1046
  22. Gotzos V , Vogt P , Celio MR . The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type . Pathol Res Pract . 1996;192:137–147
  23. Riera JR , Astengo-Osuna C , Longmate JA , et al.   The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval . Am J Surg Pathol . 1997;21:1409–1419
  24. Leers MP , Aarts MM , Theunissen PH . E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma . Histopathology . 1998;32:209–216
  25. Chhieng DC , Yee H , Schaefer D , et al.   Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions . Cancer . 2000;90:194–200
  26. Chang K , Pastan I . Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers . Proc Natl Acad Sci U S A . 1996;93:136–140
  27. Ordonez NG . Value of mesothelin immunostaining in the diagnosis of mesothelioma . Mod Pathol . 2003;16:192–197
  28. Ordonez NG . The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma . Am J Surg Pathol . 2003;27:1031–1051
  29. Miettinen M , Sarlomo-Rikala M . Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura . Am J Surg Pathol . 2003;27:150–158
  30. Youden WJ . Index for rating diagnostic tests . Cancer. . 1950;1:32–35
  31. Kojima T , Oh-eda M , Hattori K , et al.   Molecular cloning and expression of megakaryocyte potentiating factor cDNA . J Biol Chem . 1995;270:21984–21990
  32. Frierson HF , Moskaluk CA , Powell SM , et al.   Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas . Hum Pathol . 2003;34:605–609
  33. Ordonez NG . Application of mesothelin immunostaining in tumor diagnosis . Am J Surg Pathol . 2003;27:1418–1428
  34. Argani P , Iacobuzio-Donahue C , Ryu B , et al.   Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE) . Clin Cancer Res . 2001;7:3862–3868
  35. Bera TK , Pastan I . Mesothelin is not required for normal mouse development or reproduction . Mol Cell Biol . 2000;20:2902–2906

PII: S0740-2570(06)00089-X

doi: 10.1053/j.semdp.2006.06.006

Seminars in Diagnostic Pathology
Volume 23, Issue 1 , Pages 20-24 , February 2006

Article Tools

* Image Usage & Resolution